13F-HR filed by GABLES CAPITAL MANAGEMENT INC.
GABLES CAPITAL MANAGEMENT INC. filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-10, with 508 holding rows worth $276,868,013.
- Accession
- 0001740839-26-000004
- Filer
- CIK 1740839
- Filed
- 2026-08-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 508 entries on the cover page, a total value of $276,868,013 stated on the cover page (in dollars after the unit check, H1), rows summing to $276,868,013 with VALUE read as dollars as filed, 13F file number 028-18792. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Abrdn Emerging Markets | 00301W105 | COM | 6 | $58 | dollars as filed | |
| ORGANIGRAM GLOBAL INC | 68617J100 | COM | 50 | $51 | dollars as filed | |
| VANGUARD INTL EQUITY INDEX F | 922042676 | COM | 1 | $45 | dollars as filed | |
| AURORA CANNABIS INC COM | 05156X850 | Stock | 12 | $33 | dollars as filed | |
| USBC INC. | 499238202 | COM NEW | 107 | $33 | dollars as filed | |
| CEL-SCI CORP | 150837706 | COM NEW | 26 | $27 | dollars as filed | |
| Lexaria Bioscience Corp Com New | 52886N406 | Common Stock | 13 | $7 | dollars as filed | |
| 22ND CENTY GROUP INC | 90137F707 | COM | 1 | $4 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001740839-26-000004 | this filing | 2026-08-10 | acceptance time not in the bulk data set |